Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 2
2007 2
2008 2
2009 4
2010 4
2011 4
2012 1
2013 1
2014 5
2015 6
2016 7
2017 11
2018 8
2019 9
2020 5
2021 8
2022 4
2023 5
2024 11
2025 17
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Insights in Regulatory Science 2021.
Sepodes B, Mol P. Sepodes B, et al. Front Med (Lausanne). 2022 Sep 20;9:1033558. doi: 10.3389/fmed.2022.1033558. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36203766 Free PMC article. No abstract available.
Clinical Evidence 2030.
Arlett P, Umuhire D, Verpillat P, Foggi P, Wändel Liminga U, Sepodes B, Lunzer M, Aylward B, Vamvakas S, Roes K, Pétavy F, Thirstrup S, Lamas M, Cooke E, Broich K. Arlett P, et al. Among authors: sepodes b. Clin Pharmacol Ther. 2025 Apr;117(4):884-886. doi: 10.1002/cpt.3596. Epub 2025 Feb 14. Clin Pharmacol Ther. 2025. PMID: 39949283 Free PMC article. No abstract available.
Novel approaches to the stratified management of knee osteoarthritis.
Fuggle NR, Chapurlat R, Laslop A, Al-Daghri N, Alokail M, Thiyagarajan JA, Balkowiec-Iskra E, Berenbaum F, Bemden AB, Borg JJ, Bruyère O, Burlet N, Cavalier E, Rosa MM, Conaghan PG, Cooper C, Dennison EM, Englund M, Im GI, Haugen IK, Hiligsmann M, Kurth A, Lane N, Lories R, Marlovits S, Matijevic R, Mobasheri A, Ormarsdóttir S, Yerro MCP, Radermecker RP, Rannou F, Sepodes B, Silverman S, Torre C, Veronese N, Rizzoli R, Reginster JY, Harvey NC. Fuggle NR, et al. Among authors: sepodes b. Nat Rev Rheumatol. 2025 Nov;21(11):684-695. doi: 10.1038/s41584-025-01305-x. Epub 2025 Oct 3. Nat Rev Rheumatol. 2025. PMID: 41044417 Free article. Review.
Optimising bench science to withstand regulatory scrutiny.
Borg JJ, Melchiorri D, Sepodes B, Caramella CM, Tomino C, Micallef B, Serracino-Inglott A, Nistico R. Borg JJ, et al. Among authors: sepodes b. Pharmacol Res. 2019 Jan;139:491-493. doi: 10.1016/j.phrs.2018.10.014. Epub 2018 Oct 12. Pharmacol Res. 2019. PMID: 30321599 No abstract available.
The European Medicines Agency's review of elexacaftor/tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I CFTR variants.
Drai C, van der Woude HJ, Lexmond AJ, van den Hoorn T, Mol PGM, Leacy FP, Przybyszewska A, Sepodes B, Castelnovo T. Drai C, et al. Among authors: sepodes b. Eur Respir J. 2026 Jan 8;67(1):2501506. doi: 10.1183/13993003.01506-2025. Print 2026 Jan. Eur Respir J. 2026. PMID: 41067874 Free PMC article.
111 results